Weatherden

Weatherden is a global integrated clinical consultancy and experts in scientific strategy and clinical development that is trusted by biopharma, funds, startups, spin-outs and nonprofits. We advise companies from the earliest stages on scientific strategy, translational medicine and clinical development, through to diligence prep and support for M&A. Our focus is on de-risking programmes early, optimising clinical, regulatory, and commercial pathways from discovery to market and accelerating the translation of novel science into life-changing medicines for patients. Blending more than 900 years experience across the industry, we are invested in our clients success, motivated by the opportunity to rapidly improve...

Asset positioning,bioinformatics support,trial design,trial feasibility,clin ops resourcing,external expert sourcing,regulatory support,pv support,commercial landscape and competitive analysis,build companies,investor networks,consulting,business development,event management,advisory boards,ib meetings,market due diligence,and clinical trial execution

Weatherden operates in the Biotechnology research industry.

Weatherden's revenue is 11m - 100m

Weatherden has 11 - 50 employees.